Micafungin Antifungal Injection 50 mg Single Dose Powder Vial by Biocon Pharma (RX)
Sterile Antifungal Solution for Critical Fungal Infection Treatment
Superior Efficacy for Candidemia, Esophageal Candidiasis & Preventive Antifungal Therapy
Fast-Acting, Broad-Spectrum Coverage for Hospital & Outpatient Use
Micafungin for Injection 50mg by Biocon Pharma offers cutting-edge, hospital-grade treatment for life-threatening fungal infections. Formulated as a convenient, single-dose sterile powder vial, this echinocandin-class antifungal targets the most resilient fungal pathogens, including Candida and Aspergillus species. Trusted by infectious disease specialists and clinicians, this product is FDA-approved and conforms to the highest pharmaceutical manufacturing standards.
Unmatched Health Benefits
-
First-Line Therapy for Invasive Candidiasis & Candidemia: Highly effective for bloodstream Candida infections in both adult and pediatric patients.
-
Treatment of Esophageal Candidiasis: Delivers superior results for immunocompromised patients, including those with HIV/AIDS or cancer.
-
Proven Prophylaxis for Stem Cell Transplant Recipients: Provides essential antifungal prophylaxis in hematopoietic stem cell transplant (HSCT) patients at risk for invasive candidiasis.
-
Potent Echinocandin: Targeted therapeutic action against resistant Candida strains; an ideal alternative to azole and amphotericin-based therapies.
Clinical Uses & Indications
- Candidemia, Acute Disseminated Candidiasis, and Other Candida Infections
- Esophageal Candidiasis (including azole-resistant strains)
- Prophylaxis of Candida Infections in patients undergoing hematopoietic stem cell transplant
- Suitable for adults, children, and neonates when indicated by a healthcare provider
Product Specifications
- Strength: 50mg per vial (single-dose, preservative-free)
- Formulation: Sterile powder for reconstitution, IV use only
- Manufacturer: Biocon Pharma ā Trusted global leader in antifungal medications
- NDC: 70377-0075-91
How It Works
Micafungin operates by inhibiting 1,3-beta-D-glucan synthesis, an essential component of the fungal cell wall, resulting in fungus death and clearance from the body. Its targeted action reduces drug-resistance and offers minimal risk of nephrotoxicity, making it safer than amphotericin B in critically ill patients.
Why Choose Micafungin Injection by Biocon Pharma?
- Fast onset of action for acute infections
- Highly effective where other antifungals fail
- Excellent safety and tolerability profile for a broad range of patients
- Minimal drug-drug interactions for complex, critically ill patients
- Backed by leading infectious disease specialists
- Meets cGMP and FDA quality guidelines
Order Micafungin Injection 50mg Vial by Biocon Pharma (NDC: 70377-0075-91) Today ā Secure, Reliable, and Trusted by Hospitals and Pharmacists Nationwide!
For clinical use only. Consult your infectious disease specialist or healthcare provider for dosing and administration guidelines.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Micafungin Antifungal Injection 50 mg Single Dose Powder Vial by Biocon Pharma (RX)
Micafungin Antifungal Injection 50 mg Single Dose Powder Vial by Biocon Pharma (RX)
Sterile Antifungal Solution for Critical Fungal Infection Treatment
Superior Efficacy for Candidemia, Esophageal Candidiasis & Preventive Antifungal Therapy
Fast-Acting, Broad-Spectrum Coverage for Hospital & Outpatient Use
Micafungin for Injection 50mg by Biocon Pharma offers cutting-edge, hospital-grade treatment for life-threatening fungal infections. Formulated as a convenient, single-dose sterile powder vial, this echinocandin-class antifungal targets the most resilient fungal pathogens, including Candida and Aspergillus species. Trusted by infectious disease specialists and clinicians, this product is FDA-approved and conforms to the highest pharmaceutical manufacturing standards.
Unmatched Health Benefits
-
First-Line Therapy for Invasive Candidiasis & Candidemia: Highly effective for bloodstream Candida infections in both adult and pediatric patients.
-
Treatment of Esophageal Candidiasis: Delivers superior results for immunocompromised patients, including those with HIV/AIDS or cancer.
-
Proven Prophylaxis for Stem Cell Transplant Recipients: Provides essential antifungal prophylaxis in hematopoietic stem cell transplant (HSCT) patients at risk for invasive candidiasis.
-
Potent Echinocandin: Targeted therapeutic action against resistant Candida strains; an ideal alternative to azole and amphotericin-based therapies.
Clinical Uses & Indications
- Candidemia, Acute Disseminated Candidiasis, and Other Candida Infections
- Esophageal Candidiasis (including azole-resistant strains)
- Prophylaxis of Candida Infections in patients undergoing hematopoietic stem cell transplant
- Suitable for adults, children, and neonates when indicated by a healthcare provider
Product Specifications
- Strength: 50mg per vial (single-dose, preservative-free)
- Formulation: Sterile powder for reconstitution, IV use only
- Manufacturer: Biocon Pharma ā Trusted global leader in antifungal medications
- NDC: 70377-0075-91
How It Works
Micafungin operates by inhibiting 1,3-beta-D-glucan synthesis, an essential component of the fungal cell wall, resulting in fungus death and clearance from the body. Its targeted action reduces drug-resistance and offers minimal risk of nephrotoxicity, making it safer than amphotericin B in critically ill patients.
Why Choose Micafungin Injection by Biocon Pharma?
- Fast onset of action for acute infections
- Highly effective where other antifungals fail
- Excellent safety and tolerability profile for a broad range of patients
- Minimal drug-drug interactions for complex, critically ill patients
- Backed by leading infectious disease specialists
- Meets cGMP and FDA quality guidelines
Order Micafungin Injection 50mg Vial by Biocon Pharma (NDC: 70377-0075-91) Today ā Secure, Reliable, and Trusted by Hospitals and Pharmacists Nationwide!
For clinical use only. Consult your infectious disease specialist or healthcare provider for dosing and administration guidelines.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Sterile Antifungal Solution for Critical Fungal Infection Treatment
Superior Efficacy for Candidemia, Esophageal Candidiasis & Preventive Antifungal Therapy
Fast-Acting, Broad-Spectrum Coverage for Hospital & Outpatient Use
Micafungin for Injection 50mg by Biocon Pharma offers cutting-edge, hospital-grade treatment for life-threatening fungal infections. Formulated as a convenient, single-dose sterile powder vial, this echinocandin-class antifungal targets the most resilient fungal pathogens, including Candida and Aspergillus species. Trusted by infectious disease specialists and clinicians, this product is FDA-approved and conforms to the highest pharmaceutical manufacturing standards.
Unmatched Health Benefits
-
First-Line Therapy for Invasive Candidiasis & Candidemia: Highly effective for bloodstream Candida infections in both adult and pediatric patients.
-
Treatment of Esophageal Candidiasis: Delivers superior results for immunocompromised patients, including those with HIV/AIDS or cancer.
-
Proven Prophylaxis for Stem Cell Transplant Recipients: Provides essential antifungal prophylaxis in hematopoietic stem cell transplant (HSCT) patients at risk for invasive candidiasis.
-
Potent Echinocandin: Targeted therapeutic action against resistant Candida strains; an ideal alternative to azole and amphotericin-based therapies.
Clinical Uses & Indications
- Candidemia, Acute Disseminated Candidiasis, and Other Candida Infections
- Esophageal Candidiasis (including azole-resistant strains)
- Prophylaxis of Candida Infections in patients undergoing hematopoietic stem cell transplant
- Suitable for adults, children, and neonates when indicated by a healthcare provider
Product Specifications
- Strength: 50mg per vial (single-dose, preservative-free)
- Formulation: Sterile powder for reconstitution, IV use only
- Manufacturer: Biocon Pharma ā Trusted global leader in antifungal medications
- NDC: 70377-0075-91
How It Works
Micafungin operates by inhibiting 1,3-beta-D-glucan synthesis, an essential component of the fungal cell wall, resulting in fungus death and clearance from the body. Its targeted action reduces drug-resistance and offers minimal risk of nephrotoxicity, making it safer than amphotericin B in critically ill patients.
Why Choose Micafungin Injection by Biocon Pharma?
- Fast onset of action for acute infections
- Highly effective where other antifungals fail
- Excellent safety and tolerability profile for a broad range of patients
- Minimal drug-drug interactions for complex, critically ill patients
- Backed by leading infectious disease specialists
- Meets cGMP and FDA quality guidelines
Order Micafungin Injection 50mg Vial by Biocon Pharma (NDC: 70377-0075-91) Today ā Secure, Reliable, and Trusted by Hospitals and Pharmacists Nationwide!
For clinical use only. Consult your infectious disease specialist or healthcare provider for dosing and administration guidelines.
